Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repair

Nat Cardiovasc Res. 2024 Feb;3(2):186-202. doi: 10.1038/s44161-023-00411-x. Epub 2024 Jan 17.

Abstract

Tissue repair after myocardial infarction (MI) is guided by autocrine and paracrine-acting proteins. Deciphering these signals and their upstream triggers is essential when considering infarct healing as a therapeutic target. Here we perform a bioinformatic secretome analysis in mouse cardiac endothelial cells and identify cysteine-rich with EGF-like domains 2 (CRELD2), an endoplasmic reticulum stress-inducible protein with poorly characterized function. CRELD2 was abundantly expressed and secreted in the heart after MI in mice and patients. Creld2-deficient mice and wild-type mice treated with a CRELD2-neutralizing antibody showed impaired de novo microvessel formation in the infarct border zone and developed severe postinfarction heart failure. CRELD2 protein therapy, conversely, improved heart function after MI. Exposing human coronary artery endothelial cells to recombinant CRELD2 induced angiogenesis, associated with a distinct phosphoproteome signature. These findings identify CRELD2 as an angiogenic growth factor and unravel a link between endoplasmic reticulum stress and ischemic tissue repair.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inducing Agents / metabolism
  • Angiogenesis Inducing Agents / pharmacology
  • Animals
  • Cells, Cultured
  • Disease Models, Animal
  • Endoplasmic Reticulum Stress* / drug effects
  • Endothelial Cells* / drug effects
  • Endothelial Cells* / metabolism
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myocardial Infarction* / metabolism
  • Myocardial Infarction* / pathology
  • Neovascularization, Physiologic* / drug effects
  • Signal Transduction / drug effects

Substances

  • Angiogenesis Inducing Agents
  • CRELD2 protein, mouse